Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M68,904Revenue $M6,932Net Margin (%)26.9Z-Score14.1
Enterprise Value $M68,277EPS $7.8Operating Margin %36.3F-Score7
P/E(ttm))37.2Cash Flow Per Share $7.4Pre-tax Margin (%)35.8Higher ROA y-yY
Price/Book7.910-y EBITDA Growth Rate %25.7Quick Ratio1.4Cash flow > EarningsY
Price/Sales10.05-y EBITDA Growth Rate %20.1Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %35.7ROA % (ttm)15.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)21.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M238ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBRay Dalio 2013-12-31 Add0.03%$223.85 - $295.88
($258.53)
$ 291.4813%Add 208.67%19,057
BIIBJohn Hussman 2013-12-31 Sold Out -0.99%$223.85 - $295.88
($258.53)
$ 291.4813%Sold Out0
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 291.4813%Reduce -39.09%884,000
BIIBJohn Hussman 2013-09-30 Add0.33%$206.53 - $248.13
($223.63)
$ 291.4830%Add 50%75,000
BIIBMario Gabelli 2013-09-30 Add$206.53 - $248.13
($223.63)
$ 291.4830%Add 81.87%3,310
BIIBRay Dalio 2013-09-30 Reduce-0.01%$206.53 - $248.13
($223.63)
$ 291.4830%Reduce -41.27%6,174
BIIBFrank Sands 2013-06-30 Add0.71%$192.77 - $240.86
($213.68)
$ 291.4836%Add 27.6%4,565,921
BIIBMario Gabelli 2013-06-30 Reduce$192.77 - $240.86
($213.68)
$ 291.4836%Reduce -25.1%1,820
BIIBJohn Hussman 2013-06-30 Reduce-1.45%$192.77 - $240.86
($213.68)
$ 291.4836%Reduce -80.62%50,000
BIIBPRIMECAP Management 2013-06-30 Reduce-0.28%$192.77 - $240.86
($213.68)
$ 291.4836%Reduce -5%18,246,809
BIIBRay Dalio 2013-06-30 Reduce-0.07%$192.77 - $240.86
($213.68)
$ 291.4836%Reduce -78.85%10,512
BIIBFrank Sands 2013-03-31 Buy 2.4%$142.82 - $192.618
($161.38)
$ 291.4881%New holding, 3578308 sh.3,578,308
BIIBRay Dalio 2013-03-31 Add0.06%$142.82 - $192.618
($161.38)
$ 291.4881%Add 172.25%49,712
BIIBJohn Hussman 2013-03-31 Reduce-0.92%$142.82 - $192.618
($161.38)
$ 291.4881%Reduce -48.4%258,000
BIIBRay Dalio 2012-12-31 Reduce-0.08%$135.61 - $154.22
($147.04)
$ 291.4898%Reduce -69.97%18,260
BIIBJoel Greenblatt 2012-12-31 Sold Out -0.02%$135.61 - $154.22
($147.04)
$ 291.4898%Sold Out0
BIIBRay Dalio 2012-09-30 Buy 0.12%$139.09 - $156.06
($146.73)
$ 291.4899%New holding, 60804 sh.60,804
BIIBJoel Greenblatt 2012-09-30 Buy 0.02%$139.09 - $156.06
($146.73)
$ 291.4899%New holding, 2172 sh.2,172
BIIBJohn Hussman 2012-09-30 Reduce-1.35%$139.09 - $156.06
($146.73)
$ 291.4899%Reduce -50%500,000
BIIBVanguard Health Care Fund 2012-09-30 Reduce-0.44%$139.09 - $156.06
($146.73)
$ 291.4899%Reduce -29.28%1,570,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ray Dalio 2013-12-3119,0570.010.04+208.67%
BIIB Mario Gabelli 2013-12-313,71000.01+12.08%
BIIB Frank Sands 2013-12-314,754,16023.5+2.57%
BIIB PRIMECAP Management 2013-12-3117,777,6027.486-1.06%
BIIB Vanguard Health Care Fund 2013-12-31884,0000.370.76-39.09%
BIIB John Hussman 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2014-04-01Sell2,123$308.42-7.43view
PANGIA ROBERT WDirector 2014-04-01Sell6,250$308.42-7.43view
Posner Brian SDirector 2014-03-31Sell3,000$296.76-3.8view
DORSA CAROLINEDirector 2014-03-20Sell10,000$348.88-18.17view
WILLIAMS DOUGLAS EEVP Research & Development 2014-03-19Sell3,505$352.29-18.96view
Holtzman Steven HEVP Corporate Development 2014-03-17Sell1,221$334.83-14.74view
Kingsley Stuart AEVP, Global Comm. Operations 2014-03-11Sell8,428$336.83-15.24view
LEAMING NANCYDirector 2014-03-10Sell2,000$327.65-12.87view
SCANGOS GEORGE ACEO 2014-03-10Sell26,124$333.77-14.47view
Sandrock AlfredGrp SVP, Chief Medical Officer 2014-03-04Sell3,171$342.58-16.66view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
PRIMECAP Trims Top Biotechs and More Aug 30 2013 
Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE Sep 24 2012 
Weekly Top Insider Sells: GOOG, FIS, ORCL, and BIIB Aug 06 2012 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
Bearish John Hussman Sold Heavily in the First Quarter; New Portfolio Update May 02 2012 
Questcor: A Highly Shorted Stock To Watch This Year Apr 14 2012 
5 Pharmaceutical Stocks to Buy, 1 to Avoid Dec 19 2011 

More From Our Partners
Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog Apr 15 2014 - ZACKS

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide